Lausanne, January 8, 2025 – Leman Biotech Co., Ltd. ("Leman Biotech"), a clinical-stage biotechnology company focused on the research, development, production, and commercialization of innovative metabolic immunotherapies, is thrilled to announce that its co-founder, Prof. Li Tang, has been named one of the two recipients of the Friedrich Miescher Award 2025!
Prof. Tang shares this prestigious honor with Dr. Claudia Keller Valsecchi of the Institute of Molecular Biology in Mainz, Germany. The award recognizes Prof. Tang for his groundbreaking work in developing multidimensional immunoengineering approaches to enhance cancer immunotherapies, underscoring his unwavering commitment to innovation and excellence in the fight against cancer.
The Friedrich Miescher Award is Switzerland’s highest distinction for outstanding achievements in biochemistry. Established in 1969 to commemorate the 100th anniversary of Friedrich Miescher’s discovery of DNA, the award celebrates exceptional contributions to the life sciences. It is awarded to scientists under the age of 40 who are either Swiss citizens or have conducted their research in Switzerland.
Prof. Tang's academic journey is a testament to his dedication to advancing science. He earned his B.S. in Chemistry from Peking University, China, in 2007, and his Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign, USA, in 2012, under the mentorship of Prof. Jianjun Cheng. Following this, he pursued postdoctoral research as a CRI Irvington Fellow in the lab of Prof. Darrell Irvine at the Massachusetts Institute of Technology.
In 2016, Prof. Tang joined EPFL’s Institute of Bioengineering and Institute of Materials Science & Engineering as a Tenure-Track Assistant Professor, earning a promotion to Associate Professor in 2022. His accolades include numerous international research awards, such as the CAB Mid-Career Investigator Award (2024), Biomaterials Award for Young Investigators (2024), Anna Fuller Award (2022, 2011), Cancer Research Institute CLIP Award (2021), and the European Research Council (ERC) Starting Grant (2018). He was also featured in MIT Technology Review’s "Top 35 Innovators under Age 35" for China in 2020.
(1).png)
The official award ceremony will take place during the Life Sciences Switzerland (LS2) Annual Meeting 2025, on February 13, 2025, at 4:10 PM at the University of Fribourg.
We at Leman Biotech are proud to celebrate Prof. Tang’s exceptional achievements and his contributions to advancing the frontiers of cancer immunotherapy.
